We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.95%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$39.9B
AUM Growth
+$891M
(+2.3%)
Cap. Flow
-$1.96B
Cap. Flow
% of AUM
-4.91%
Top 10 Holdings %
Top 10 Hldgs %
26.01%
Holding
846
New
122
Increased
198
Reduced
391
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$171M |
| 2 |
Sensata Technologies
ST
|
+$145M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$133M |
| 4 |
Amazon
AMZN
|
+$67.2M |
| 5 |
AbbVie
ABBV
|
+$65.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Otis Worldwide
OTIS
|
+$164M |
| 2 |
Ross Stores
ROST
|
+$110M |
| 3 |
Bank of America
BAC
|
+$94.4M |
| 4 |
Freeport-McMoran
FCX
|
+$92.4M |
| 5 |
Five Below
FIVE
|
+$89.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.1% |
| 2 | Healthcare | 19.47% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Financials | 11.29% |
| 5 | Communication Services | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Knight Transportation
KNX
$11.3B
| $20.3M | 0.05% |
498,959
-877,932
| -64% | -$38.5M |
|
377
Equity Residential
EQR
$25.1B
| $20.2M | 0.05% |
393,833
-12,400
| -3% | -$686K |
|
|
CRHC.U
378
DELISTED
Cohn Robbins Holdings Corp. Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
CRHC.U
| $20.2M | 0.05% |
+2,000,000
| New | +$20.3M |
|
379
Akamai
AKAM
$17.1B
| $20.1M | 0.05% |
182,100
-5,900
| -3% | -$655K |
|
|
MXIM
380
DELISTED
Maxim Integrated Products
MXIM
| $20.1M | 0.05% |
296,800
+126,400
| +74% | +$8.55M |
|
|
AMK
381
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $20.1M | 0.05% |
922,792
-25,731
| -3% | -$648K |
|
382
Ball Corp
BALL
$16.7B
| $19.8M | 0.05% |
237,904
+107
| +0% | +$8.23K |
|
383
Illumina
ILMN
$28.7B
| $19.5M | 0.05% |
64,720
-110,325
| -63% | -$38M |
|
384
Amcor
AMCR
$22.1B
| $19.3M | 0.05% |
349,718
-11,360
| -3% | -$618K |
|
385
Eaton
ETN
$175B
| $19.3M | 0.05% |
+189,206
| New | +$18.5M |
|
386
CMS Energy
CMS
$22.2B
| $19.3M | 0.05% |
+313,800
| New | +$19.2M |
|
387
Bank of N.T. Butterfield & Son
NTB
$2.44B
| $19.1M | 0.05% |
859,388
-47,637
| -5% | -$1.19M |
|
388
Travelers Companies
TRV
$80B
| $19.1M | 0.05% |
176,894
-309,200
| -64% | -$35.4M |
|
389
CDW
CDW
$17.2B
| $19.1M | 0.05% |
159,600
-5,200
| -3% | -$595K |
|
390
Conagra Brands
CAG
$7.15B
| $19.1M | 0.05% |
533,645
-17,700
| -3% | -$648K |
|
|
SIVB
391
DELISTED
SVB Financial Group
SIVB
| $19M | 0.05% |
78,900
-25,900
| -25% | -$6.09M |
|
|
KSU
392
DELISTED
Kansas City Southern
KSU
| $19M | 0.05% |
104,900
-7,600
| -7% | -$1.32M |
|
|
MRNS
393
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $18.8M | 0.05% |
1,462,500
-112,500
| -7% | -$971K |
|
394
Gilead Sciences
GILD
$165B
| $18.6M | 0.05% |
+294,977
| New | +$20.5M |
|
|
ADN
395
DELISTED
Advent Technologies
ADN
| $18.6M | 0.05% |
60,000
| – | – |
|
396
Cooper Companies
COO
$14.4B
| $18.5M | 0.05% |
219,932
+195,200
| +789% | +$15M |
|
397
Penumbra
PEN
$12.8B
| $18.5M | 0.05% |
+95,000
| New | +$20M |
|
398
3M
MMM
$93.7B
| $18.3M | 0.05% |
+136,848
| New | +$18.4M |
|
399
Genmab
GMAB
$19.3B
| $18.3M | 0.05% |
+500,000
| New | +$18.1M |
|
400
Tractor Supply
TSCO
$17.6B
| $18.3M | 0.05% |
638,500
-21,000
| -3% | -$603K |
|
Similar funds
Adage Capital Partners's Q3 2020 Portfolio in Review
As of Q3 2020, Adage Capital Partners held 846 positions worth $39.9B, up 2.3% from $39.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Adage Capital Partners withdrew a net $1.96B in Q3 2020, closing 98 positions and reducing 391 holdings. Its most notable exit was Pfizer, an estimated $60.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Bristol-Myers Squibb worth $134M.
- Adage Capital Partners's largest Q3 2020 buy was Bristol-Myers Squibb: 2,215,804 shares worth $134M.
- Adage Capital Partners added most to Johnson & Johnson in Q3 2020, an estimated $171M increase.
- Adage Capital Partners's biggest Q3 2020 reduction was Otis Worldwide, cutting an estimated $164M.
- Adage Capital Partners fully exited Pfizer in Q3 2020, selling an estimated $60.9M.
- Adage Capital Partners's ten largest holdings make up 26% of its $39.9B portfolio in Q3 2020.
- Adage Capital Partners opened 122 new positions and closed 98 in Q3 2020.
- Adage Capital Partners's portfolio value rose 2.3% quarter-over-quarter to $39.9B.
Based on Adage Capital Partners's 13F filing for Q3 2020, filed 16 Nov 2020.